1. Home
  2. DINO vs MEDP Comparison

DINO vs MEDP Comparison

Compare DINO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Sinclair Corporation

DINO

HF Sinclair Corporation

HOLD

Current Price

$91.70

Market Cap

12.9B

Sector

Energy

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$530.93

Market Cap

15.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DINO
MEDP
Founded
1947
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Commercial Physical & Biological Resarch
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
15.4B
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
DINO
MEDP
Price
$91.70
$530.93
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$61.50
$473.17
AVG Volume (30 Days)
2.3M
312.5K
Earning Date
05-01-2026
04-22-2026
Dividend Yield
3.03%
N/A
EPS Growth
238.46
20.98
EPS
3.56
4.28
Revenue
N/A
N/A
Revenue This Year
$8.01
$13.19
Revenue Next Year
N/A
$7.75
P/E Ratio
$25.40
$123.35
Revenue Growth
N/A
N/A
52 Week Low
$42.16
$373.00
52 Week High
$91.45
$628.92

Technical Indicators

Market Signals
Indicator
DINO
MEDP
Relative Strength Index (RSI) 82.76 56.94
Support Level $47.04 $525.92
Resistance Level N/A $530.97
Average True Range (ATR) 2.55 17.19
MACD 1.63 -3.92
Stochastic Oscillator 93.90 27.49

Price Performance

Historical Comparison
DINO
MEDP

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: